The importance of truncal somatic mutations in MRD testing
Haystack MRD™ prioritizes truncal somatic mutations those mutations that are present at the initial formation of a tumor or the trunk of the cancer evolutionary tree
Haystack MRD™ prioritizes truncal somatic mutations those mutations that are present at the initial formation of a tumor or the trunk of the cancer evolutionary tree
One of the most critical differentiators among minimal residual disease MRD tests is whether they are tumor informed or whether they are tumor naive
The landmark DYNAMIC study is the first prospective randomized interventional trial to demonstrate the clinical benefit of MRD testing to guide adjuvant therapy
Haystack MRD™ strikes the right balance of DNA molecules interrogated and number of mutations tracked for optimizing test efficiency and sustainability
Connect with us
Social:
Social:
Social:
Social:
Social:
Social:
Social:
Social:
Social:
Social:
Social:
Social:
Social:
Social:
Social:
Social: